de la Torre, A. 2023. Evolving role of novel therapies in myeloma: T-cell engagers and antibody-drug conjugates. Canadian Hematology Today. 2, 2 (Jun. 2023), 16–19. DOI:https://doi.org/10.58931/cht.2023.2233.